Pentraxin-3 is not related to disease severity in cirrhosis and hepatocellular carcinoma patients

Long Pentraxin 3 as a Broader Biomarker for Multiple Risk Factors in End-Stage Renal Disease: Association with All-Cause Mortality

(2019) Maria João Valente et al.   MEDIATORS OF INFLAMMATION

Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma

(2019) Susanne Feder et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Immune checkpoint therapy in liver cancer

(2018) Feng Xu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts

(2018) Arnaud J. Legrand et al.   Oncotarget

Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition

(2018) Tao Song et al.   Journal of Cancer

An update on the recent advances in antifibrotic therapy

(2018) Frank Tacke et al.   Expert Review of Gastroenterology & Hepatology

Pentraxin-3 modulates lipopolysaccharide-induced inflammatory response and attenuates liver injury

(2017) Luis Perea et al.   HEPATOLOGY

The long pentraxin PTX3: A prototypical sensor of tissue injury and a regulator of homeostasis

(2017) Marco Erreni et al.   IMMUNOLOGICAL REVIEWS

Adipokines in Liver Cirrhosis

(2017) Christa Buechler et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Serum pentraxin-3 and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) predict severity of infections in acute decompensated cirrhotic patients

(2017) Wen-Chien Fan et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Stability of pro- and anti-inflammatory immune biomarkers for human cohort studies

(2017) C. Graham et al.   Journal of Translational Medicine

Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis

(2017) Romy M. W. Kremers et al.   PLoS One

The Dual Complexity of PTX3 in Health and Disease: A Balancing Act?

(2016) Elena Magrini et al.   TRENDS IN MOLECULAR MEDICINE

An acidic microenvironment sets the humoral pattern recognition molecule PTX3 in a tissue repair mode

(2015) Andrea Doni et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV

(2015) R. F. Carmo et al.   JOURNAL OF VIRAL HEPATITIS

A Practical Guide to Immunoassay Method Validation

(2015) Ulf Andreasson et al.   Frontiers in Neurology

Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases

(2015) Valli De Re et al.   PLoS One

Plasma pentraxin-3 and coagulation and fibrinolysis variables during acute Puumala hantavirus infection and associated thrombocytopenia

(2014) Outi K. Laine et al.   BLOOD COAGULATION & FIBRINOLYSIS

Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss

(2014) Anna Witasp et al.   Obesity

Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications

(2014) Sith Siramolpiwat   WORLD JOURNAL OF GASTROENTEROLOGY

Cirrhosis and its complications: Evidence based treatment

(2014) Salman Nusrat   WORLD JOURNAL OF GASTROENTEROLOGY

Portal vein omentin is increased in patients with liver cirrhosis but is not associated with complications of portal hypertension

(2013) Kristina Eisinger et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Pathological bacterial translocation in liver cirrhosis

(2013) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Biomarkers of Coagulation, Inflammation, and Angiogenesis are Independently Associated with Preeclampsia

(2012) Roland Boij et al.   AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Liver cirrhosis

(2011) Massimo Pinzani et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis

(2011) Erfan Nur et al.   BLOOD CELLS MOLECULES AND DISEASES

Systemic and hepatic vein galectin-3 are increased in patients with alcoholic liver cirrhosis and negatively correlate with liver function

(2011) Josef Wanninger et al.   CYTOKINE

TIPS for the treatment of refractory ascites, hepatorenal syndrome and hepatic hydrothorax: a critical update

(2010) M. Rossle et al.   GUT

Circulating pentraxin 3 levels are higher in metabolic syndrome with subclinical atherosclerosis: evidence for association with atherogenic lipid profile

(2009) Michela Zanetti et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Hepatic fibrosis

(2009) Jingjing Jiao et al.   CURRENT OPINION IN GASTROENTEROLOGY

Peritoneal fluid adipokines: ready for prime time?

(2009) R. Wiest et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)

(2008) Masato Yoneda et al.   BMC GASTROENTEROLOGY